Dermatology · Wildomar, CA
NPI
1417975905
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
23905 Clinton Keith Rd Ste 114
Wildomar, CA, 92595
Phone (951) 672-7673
Medicare paid, 2024
$127K
2,409 services
Medicare patients, 2024
512
Average age 74
Drug cost, 2024
$1.5M
3,048 prescriptions
Company payments, 2025
$1,780
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randolph J Jacobs was code 17003 (destruction skin lesion), 834 times for 173 patients. In total Randolph J Jacobs billed 2,409 services in 66 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 834 | 173 | $4.65 | $3,882 |
| 17000 Destruction Skin Lesion | Office | 277 | 201 | $32.91 | $9,117 |
| 99213 Office E&M - Established | Office | 250 | 190 | $59.38 | $15K |
| 99212 Office E&M - Established | Office | 229 | 171 | $35.62 | $8,158 |
| 11102 Skin Biopsy | Office | 162 | 139 | $55.16 | $8,936 |
| 99203 Office E&M - New | Office | 102 | 102 | $73.07 | $7,453 |
| 17110 Destruction Skin Lesion | Office | 89 | 80 | $71.24 | $6,341 |
| 99202 Office E&M - New | Office | 79 | 79 | $45.93 | $3,628 |
| 11103 Skin Biopsy | Office | 72 | 38 | $35.29 | $2,541 |
| 17311 Mohs Surgery | Office | 46 | 39 | $422.50 | $19K |
| 11104 Skin Biopsy | Office | 21 | 21 | $75.08 | $1,577 |
| 13132 Wound Repair - All Levels | Office | 19 | 17 | $197.37 | $3,750 |
| 11606 Skin Lesion Excision | Office | 17 | 16 | $310.54 | $5,279 |
| 13121 Wound Repair - All Levels | Office | 17 | 17 | $187.22 | $3,183 |
| 10060 Skin | Office | 15 | 15 | $86.92 | $1,304 |
By year: 2022 $109K for 2,313 services; 2023 $144K for 2,728 services; 2024 $127K for 2,409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randolph J Jacobs prescribed most often to Medicare patients was Hydrocortisone, with 633 prescriptions and refills. In total Randolph J Jacobs wrote 3,048 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocortisone Generic | 633 | 678 | 428 | $10K |
| Fluorouracil Generic | 489 | 517 | 333 | $36K |
| Cephalexin Generic | 304 | 304 | 274 | $1,704 |
| Triamcinolone Acetonide Generic | 201 | 241 | 126 | $3,533 |
| Doxycycline Hyclate Generic | 162 | 222 | 65 | $7,813 |
| Ketoconazole Generic | 150 | 164 | 76 | $4,641 |
| Clobetasol Propionate Generic | 143 | 156 | 84 | $5,069 |
| Ammonium Lactate Generic | 95 | 105 | 47 | $1,982 |
| Adapalene Generic | 77 | 83 | 44 | $4,965 |
| Griseofulvin Ultramicrosize Generic | 47 | 57 | 14 | $9,464 |
| Ciclopirox Generic | 46 | 50 | 23 | $1,116 |
| Ciprofloxacin Hcl Generic | 46 | 46 | 42 | $347 |
| Dupixent Pen Dupilumab | 39 | 43 | 11 | $161K |
| Hydroxyzine Hcl Generic | 35 | 75 | 18 | $300 |
| Opzelura Ruxolitinib Phosphate | 35 | 35 | Under 11 | $82K |
Brand drugs: 230 claims; generic drugs: 2,818 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randolph J Jacobs $1,780 ($1,780 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $256.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $256 |
| LEO Pharma Inc. | 15 | $239 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $223 |
| UCB, Inc. UCB.BR | 7 | $202 |
| Genzyme Corporation SNY | 5 | $170 |
| Lilly USA, LLC LLY | 6 | $167 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $143 |
| Pfizer Inc. PFE | 6 | $131 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $59.56 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.